Express Pharma - Page 60 of 2240 - Express Pharma

Government caps margins on cancer medicines at 30%, targets ₹2,500 Cr annual savings

Lupin receives USFDA approval for Phytonadione Injectable Emulsion

Why industry-academia collaboration will shape India’s next R&D chapter

OPPI collaborates with NIPER Rae Bareli to advance research excellence

Merck expands Bengaluru facility to boost global supply of filtration devices

Lupin receives ANDA approval for Dapagliflozin, Metformin Hydrochloride extended-release tablets in US

Glenmark receives US FDA approval for Progesterone Vaginal Inserts, 100 mg

Lupin receives US FDA approval for Dapagliflozin tablets

Inventia enters the U.S. market with FDA approved Dapagliflozin tablets

Biocon launches Bosaya and Aukelso in the United States

Alembic Pharmaceuticals secures USFDA approval for Dapagliflozin Tablets ANDA

Lupin receives Great Place To Work certification across global operations

CuraTeQ Biologics reports Phase 3 results for BP11 biosimilar to Xolair